125 related articles for article (PubMed ID: 16177662)
1. Hepatic manifestations of Epstein-Barr viral infection.
Méndez-Sánchez N; Aguilar-Domínguez C; Chávez-Tapia NC; Uribe M
Ann Hepatol; 2005; 4(3):205-9. PubMed ID: 16177662
[TBL] [Abstract][Full Text] [Related]
2. Measurement of EBV-IgG anti-VCA avidity aids the early and reliable diagnosis of primary EBV infection.
Robertson P; Beynon S; Whybin R; Brennan C; Vollmer-Conna U; Hickie I; Lloyd A
J Med Virol; 2003 Aug; 70(4):617-23. PubMed ID: 12794726
[TBL] [Abstract][Full Text] [Related]
3. Anti-Epstein-Barr virus antibodies in Beijing during 2013-2017: What we have found in the different patients.
Cui J; Yan W; Xu S; Wang Q; Zhang W; Liu W; Ni A
PLoS One; 2018; 13(3):e0193171. PubMed ID: 29494658
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis.
Nystad TW; Myrmel H
J Clin Virol; 2007 Apr; 38(4):292-7. PubMed ID: 17336144
[TBL] [Abstract][Full Text] [Related]
5. Evaluation the Architect EBV VCA IgM, VCA IgG, and EBNA-1 IgG chemiluminescent immunoassays to assess EBV serostatus prior transplantation.
Maylin S; Feghoul L; Salmona M; Herda A; Mercier-Delarue S; Simon F; Legoff J
J Med Virol; 2017 Nov; 89(11):2003-2010. PubMed ID: 28661055
[TBL] [Abstract][Full Text] [Related]
6. [Epstein-Barr virus infection and acute cholestatic hepatitis].
Barreales M; Pérez-Carreras M; Meizoso T; Garrido M; Masedo A; Colina F; Solís JA
An Med Interna; 2006 Oct; 23(10):483-6. PubMed ID: 17134311
[TBL] [Abstract][Full Text] [Related]
7. [Atypical profile problem in serological diagnosis of EBV].
Varıcı Balcı FK; Özbek ÖA; Sayıner AA
Mikrobiyol Bul; 2017 Oct; 51(4):378-386. PubMed ID: 29153068
[TBL] [Abstract][Full Text] [Related]
8. Cholestatic hepatitis induced by Epstein-Barr virus infection in an adult.
Hinedi TB; Koff RS
Dig Dis Sci; 2003 Mar; 48(3):539-41. PubMed ID: 12757167
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic Performance and Comparative Evaluation of the Architect, Liaison, and Platelia Epstein-Barr Virus Antibody Assays.
Park Y; Park BG; Ha J; Kim HS
Ann Lab Med; 2018 Sep; 38(5):458-465. PubMed ID: 29797817
[TBL] [Abstract][Full Text] [Related]
10. [Polyclonal activation due to Epstein-Barr virus superinfection in a case with chronic hepatitis B].
Bakir Ozbey S; Mistik R; Gürcüoğlu E; Oral B; Göral G
Mikrobiyol Bul; 2007 Oct; 41(4):607-12. PubMed ID: 18173082
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of PCR results in the diagnosis of Epstein-Barr virus infections].
Karadağ Geçgel S; Ersoy A; Sevinir BB; Sınırtaş M; Göral G
Mikrobiyol Bul; 2012 Oct; 46(4):594-606. PubMed ID: 23188573
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus and Interleukin-28B polymorphism in the prediction of response to interferon therapy in hepatitis C patients.
Zekri AR; Abdullah D; Osman A; El-Rouby MN; Zayed N; Esmat G; Elakel W; Hafez HA
Arab J Gastroenterol; 2015; 16(3-4):84-9. PubMed ID: 26526510
[TBL] [Abstract][Full Text] [Related]
13. Chronic Epstein-Barr virus-related hepatitis in immunocompetent patients.
Petrova M; Muhtarova M; Nikolova M; Magaev S; Taskov H; Nikolovska D; Krastev Z
World J Gastroenterol; 2006 Sep; 12(35):5711-6. PubMed ID: 17007027
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the abbot Architect(™) epstein-barr virus viral capsid antigen IgM, viral capsid antigen IgG and nuclear antigen IgG assays in a pediatric and adult population.
Grandjean Lapierre S; Vallières E; Rabaamad L; Labrecque M; Chartrand C; Renaud C
J Clin Virol; 2016 Aug; 81():1-5. PubMed ID: 27258036
[TBL] [Abstract][Full Text] [Related]
15. [Simultaneous detection of IgM antibodies against the hepatitis A virus and the viral capsid antigen of Epstein-Barr virus in acute hepatitis].
Naveau S; Delfraissy JF; Poitrine A; Poynard T; Chaput JC
Gastroenterol Clin Biol; 1985 Feb; 9(2):109-12. PubMed ID: 2984075
[TBL] [Abstract][Full Text] [Related]
16. Association of clinical and serological parameters of systemic lupus erythematosus patients with Epstein-Barr virus antibody profile.
Chougule D; Nadkar M; Rajadhyaksha A; Pandit-Shende P; Surve P; Dawkar N; Khadilkar P; Patwardhan M; Kaveri S; Ghosh K; Pradhan V
J Med Virol; 2018 Mar; 90(3):559-563. PubMed ID: 28734074
[TBL] [Abstract][Full Text] [Related]
17. [A case of cholestatic hepatitis induced by epstein-barr virus infection].
Park MJ; Chung IK; Park YD; Chung YJ; Lee HC; Cho HJ; Seo EH; Cho CM; Tak WY; Kim SK; Choi YW; Kweon YO
Korean J Hepatol; 2006 Jun; 12(2):237-42. PubMed ID: 16804349
[TBL] [Abstract][Full Text] [Related]
18. Quantification of Epstein-Barr virus DNA is helpful for evaluation of chronic active Epstein-Barr virus infection.
Sakamoto Y; Mariya Y; Kubo K
Tohoku J Exp Med; 2012 Aug; 227(4):307-11. PubMed ID: 22850617
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus associated acute hepatitis with cross-reacting antibodies to other herpes viruses in immunocompetent patients: report of two cases.
Gupta E; Bhatia V; Choudhary A; Rastogi A; Gupta NL
J Med Virol; 2013 Mar; 85(3):519-23. PubMed ID: 23297155
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of immunoblot-based assay for detecting Epstein-Barr virus viral capsid antibodies].
Altuğlu I; Aksoy A; Zeytinoğlu A; Orman M
Mikrobiyol Bul; 2010 Apr; 44(2):231-6. PubMed ID: 20549957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
